fostamatinib and Diabetes-Mellitus--Type-2

fostamatinib has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

Other Studies

1 other study(ies) available for fostamatinib and Diabetes-Mellitus--Type-2

Article	Year
Comment on "Therapeutic targeting of Syk in autoimmune diabetes". Journal of immunology (Baltimore, Md. : 1950), 2011, Feb-15, Volume: 186, Issue:4 Topics: Aminopyridines; Autoimmune Diseases; Diabetes Mellitus, Type 2; Glomerulonephritis; Humans; Intracellular Signaling Peptides and Proteins; Morpholines; Oxazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Reperfusion Injury; Signal Transduction; Spleen; Syk Kinase	2011

Article

Year

Comment on "Therapeutic targeting of Syk in autoimmune diabetes".

Journal of immunology (Baltimore, Md. : 1950), 2011, Feb-15, Volume: 186, Issue:4

Topics: Aminopyridines; Autoimmune Diseases; Diabetes Mellitus, Type 2; Glomerulonephritis; Humans; Intracellular Signaling Peptides and Proteins; Morpholines; Oxazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Reperfusion Injury; Signal Transduction; Spleen; Syk Kinase

2011